Three versus four cycles of neoadjuvant gemcitabine cisplatin for muscle invasive bladder cancer (MIBC).

Three versus four cycles of neoadjuvant gemcitabine cisplatin for muscle invasive bladder cancer (MIBC). Meeting Abstract

publication date

May 20, 2021

webpage

Web of Science

published in

JOURNAL OF CLINICAL ONCOLOGY Journal

volume

39

issue

15